801 related articles for article (PubMed ID: 33523318)
1. COVID-19 in patients with Down syndrome.
Emami A; Javanmardi F; Akbari A; Asadi-Pooya AA
Neurol Sci; 2021 May; 42(5):1649-1652. PubMed ID: 33523318
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil.
Boschiero MN; Palamim CVC; Ortega MM; Marson FAL
Hum Genet; 2022 Dec; 141(12):1887-1904. PubMed ID: 35763088
[TBL] [Abstract][Full Text] [Related]
3. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
Malle L; Gao C; Hur C; Truong HQ; Bouvier NM; Percha B; Kong XF; Bogunovic D
Genet Med; 2021 Mar; 23(3):576-580. PubMed ID: 33060835
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
Pediatr Blood Cancer; 2024 Aug; 71(8):e31082. PubMed ID: 38804869
[TBL] [Abstract][Full Text] [Related]
5. Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
Ku JH; Levin MJ; Luo Y; Florea A; Lin IC; Tian Y; Tseng HF
J Infect Dis; 2022 Sep; 226(5):757-765. PubMed ID: 35749312
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 presentations and outcome in patients with epilepsy.
Asadi-Pooya AA; Emami A; Akbari A; Javanmardi F
Acta Neurol Scand; 2021 Jun; 143(6):624-628. PubMed ID: 33590880
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in patients with Down syndrome: A systematic review.
Pitchan Velammal PNK; Balasubramanian S; Ayoobkhan FS; Mohan GVK; Aggarwal P; Rabaan AA; Khan SA; Yasmin F; Koritala T; Surani SR
Immun Inflamm Dis; 2024 Mar; 12(3):e1219. PubMed ID: 38501534
[TBL] [Abstract][Full Text] [Related]
8. Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil.
Leung C; Su L; Simões-E-Silva AC; Arocha LS; de Paiva KM; Haas P
Emerg Infect Dis; 2023 Jan; 29(1):26-35. PubMed ID: 36573520
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Villani ER; Carfì A; Di Paola A; Palmieri L; Donfrancesco C; Lo Noce C; Taruscio D; Meli P; Salerno P; Kodra Y; Pricci F; Tamburo de Bella M; Floridia M; Onder G;
Am J Med Genet A; 2020 Dec; 182(12):2964-2970. PubMed ID: 32918520
[TBL] [Abstract][Full Text] [Related]
10. Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome.
Malle L; Bastard P; Martin-Nalda A; Carpenter T; Bush D; Patel R; Colobran R; Soler-Palacin P; Casanova JL; Gans M; Rivière JG; Bogunovic D
J Clin Immunol; 2021 Oct; 41(7):1457-1462. PubMed ID: 34089457
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course.
Kantar A; Mazza A; Bonanomi E; Odoni M; Seminara M; Verde ID; Lovati C; Bolognini S; D'Antiga L
BMC Pediatr; 2020 Dec; 20(1):561. PubMed ID: 33339516
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK.
Baksh RA; Strydom A; Pape SE; Chan LF; Gulliford MC
J Gen Intern Med; 2022 Jun; 37(8):2009-2015. PubMed ID: 35386043
[TBL] [Abstract][Full Text] [Related]
14. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.
Asadi-Pooya AA; Akbari A; Emami A; Lotfi M; Rostamihosseinkhani M; Nemati H; Barzegar Z; Kabiri M; Zeraatpisheh Z; Farjoud-Kouhanjani M; Jafari A; Sasannia F; Ashrafi S; Nazeri M; Nasiri S; Shahisavandi M
Iran J Med Sci; 2021 Nov; 46(6):428-436. PubMed ID: 34840383
[TBL] [Abstract][Full Text] [Related]
16. Long COVID syndrome-associated brain fog.
Asadi-Pooya AA; Akbari A; Emami A; Lotfi M; Rostamihosseinkhani M; Nemati H; Barzegar Z; Kabiri M; Zeraatpisheh Z; Farjoud-Kouhanjani M; Jafari A; Sasannia S; Ashrafi S; Nazeri M; Nasiri S; Shahisavandi M
J Med Virol; 2022 Mar; 94(3):979-984. PubMed ID: 34672377
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.
Hatami H; Soleimantabar H; Ghasemian M; Delbari N; Aryannezhad S
J Res Health Sci; 2021 Feb; 21(1):e00510. PubMed ID: 34024768
[TBL] [Abstract][Full Text] [Related]
18. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
[TBL] [Abstract][Full Text] [Related]
19. An international survey on the impact of COVID-19 in individuals with Down syndrome.
Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Del Carmen Ortega M; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A
medRxiv; 2020 Nov; ():. PubMed ID: 33173907
[TBL] [Abstract][Full Text] [Related]
20. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study.
Sierra-Hidalgo F; Aragón Revilla E; Arranz García P; Martínez-Acebes E; Gómez-Moreno SM; Muñoz-Rivas N; Esquivel López A;
Neurocrit Care; 2022 Feb; 36(1):208-215. PubMed ID: 34268645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
